This on-line tool outlines a balanced approach to safer opioid prescription as part of multimodal pain management. There is strong evidence that risk increases substantially above 60 mg/day oral morphine equivalent daily dose (oMEDD). For this reason, in this resource, 60 mg oMEDD is chosen as a threshold for increased risk and recommendations are built around this level although recognising the need to consider the specific risks of each individual. In general, in the chronic non-cancer pain setting, opioids (including codeine) should be avoided other than in exceptional circumstances. These include the presence of severe opioid responsive pain where other management options have failed or are inappropriate. Opioids should not be prescribed above 60mg oMEDD without pain medicine specialist endorsement.
In this tool, you will find recommendations and resources for the management of people with chronic non-cancer pain at each stage of prescribing – whether you are considering, starting, continuing at or below 60 mg oMEDD, continuing above 60 mg oMEDD or reducing opioids. Simply click on the tabs below to find the recommendations.